Latest

Understand ALK fusion testing in lung cancer, including what a positive or negative result means, tissue and ctDNA methods, limitations, and treatment relevance.

ALK Fusion Test for Lung Cancer: Gene Fusion, Positive Result, and Molecular Meaning

Understand BRAF V600E testing in lung cancer, including what a positive or negative result means, tissue and ctDNA methods, limitations, and treatment relevance.

BRAF V600E Test for Lung Cancer: Mutation Status, Positive Result, and Molecular Meaning

Learn how the carcinoembryonic antigen (CEA) test is used in lung cancer, what high levels can mean, common non-cancer causes, reference ranges, and why serial trends matter.

CEA Test for Lung Cancer: Tumor Marker Monitoring, High Levels, and Result Meaning

Learn how the cytokeratin 19 fragment 21-1 (CYFRA 21-1) test is used in lung cancer, what high levels can mean, common non-cancer causes, reference ranges, and why serial trends matter.

CYFRA 21-1 Test for Lung Cancer: Tumor Marker Levels and Disease Monitoring

Understand EGFR exon 20 insertion testing in lung cancer, including what a positive or negative result means, tissue and ctDNA methods, limitations, and treatment relevance.

EGFR Exon 20 Insertion Test: Lung Cancer Mutation Status and Molecular Meaning

Understand EGFR mutation testing in lung cancer, including what a positive or negative result means, tissue and ctDNA methods, limitations, and treatment relevance.

EGFR Mutation Test for Lung Cancer: Exon 19, L858R, T790M, Mutation Status, and...

Diagnostics

Home Diagnostics Page 51

Understand what an ASXL1 mutation test shows in blood and bone marrow, how results relate to myeloid neoplasms and clonal hematopoiesis, and how they affect prognosis and follow-up.

ASXL1 Mutation Test: Blood Cancer, Myeloid Neoplasm, and Results

Learn what an ATM genetic test shows, how positive, negative, and uncertain results affect breast and other cancer risk, and how screening and family testing are planned.

ATM Genetic Test: Breast Cancer Risk, DNA Repair, and Results

Learn what a BAP1 genetic test shows, how results relate to melanoma, mesothelioma, and kidney cancer risk, and how surveillance and family testing are planned.

BAP1 Genetic Test: Melanoma, Mesothelioma, Kidney Cancer Risk, and Results

Understand what a BCL2 rearrangement test shows, how results support follicular lymphoma diagnosis, and why concurrent MYC and BCL2 rearrangements identify double-hit lymphoma.

BCL2 Rearrangement Test: Follicular Lymphoma, Double-Hit Lymphoma, and Results

Learn what a BCL6 rearrangement test shows, how positive and negative results are interpreted, and how BCL6, MYC, and BCL2 findings affect lymphoma classification and prognosis.

BCL6 Rearrangement Test: Lymphoma, Prognosis, and Results

Understand BCR-ABL1 testing for CML and Philadelphia-positive leukemia, including diagnostic methods, International Scale results, molecular response milestones, and resistance testing.

BCR-ABL1 Test: CML, Leukemia, Philadelphia Chromosome, and Results

Understand BRAF mutation testing in melanoma, colorectal, thyroid, and lung cancer, including V600E results, testing methods, targeted therapy, and negative-test limitations.

BRAF Mutation Test: Melanoma, Colon, Thyroid, Lung Cancer, and Results

Understand BRCA1 and BRCA2 genetic testing, cancer risks, positive, negative, and VUS results, screening, preventive surgery, treatment options, and family testing.

BRCA1 and BRCA2 Genetic Test: Cancer Risk, Mutations, and Results

Understand CALR mutation testing for high platelets, essential thrombocythemia, and primary myelofibrosis, including type 1 and type 2 results, prognosis, and follow-up.

CALR Mutation Test: Myeloproliferative Neoplasm, Platelets, and Results

Understand the CCND1/IGH fusion test for mantle cell lymphoma, including t(11;14), FISH results, cyclin D1 and SOX11 findings, prognosis, and diagnostic limits.

CCND1/IGH Fusion Test: Mantle Cell Lymphoma and Results

Understand CDH1 genetic testing, diffuse gastric and lobular breast cancer risks, positive and VUS results, expert endoscopy, preventive gastrectomy, and family testing.

CDH1 Genetic Test: Hereditary Diffuse Gastric Cancer Risk and Results

Understand CEBPA mutation testing in AML, including in-frame bZIP results, favorable-risk classification, germline familial leukemia, treatment, MRD, and test limitations.

CEBPA Mutation Test: AML Prognosis, Leukemia Genetics, and Results

Understand CHEK2 genetic test results, variant-specific breast cancer risk, changing colon guidance, prostate screening, inheritance, family testing, and next steps.

CHEK2 Genetic Test: Breast, Colon, Prostate Cancer Risk, and Results

Understand ctDNA test results for liquid biopsy profiling, targeted therapy, treatment response, molecular residual disease, recurrence risk, false negatives, and follow-up.

Circulating Tumor DNA (ctDNA) Test: Cancer Monitoring, Mutations, and Results

Understand comprehensive genomic profiling results, tissue and liquid testing, actionable mutations, MSI, TMB, possible germline findings, limitations, and treatment matches.

Comprehensive Genomic Profiling Test: Cancer Genes, Mutations, and Results

Understand DICER1 genetic test results, pleuropulmonary blastoma and other tumor risks, mosaicism, childhood and adult surveillance, inheritance, and family testing.

DICER1 Genetic Test: Tumor Predisposition, Cancer Risk, and Results

Learn how a DNMT3A mutation test is used in AML and clonal hematopoiesis, what variant allele frequency means, and how positive, negative, and persistent results are interpreted.

DNMT3A Mutation Test: AML, Clonal Hematopoiesis, and Results

Understand EGFR mutation testing for lung cancer, including tissue and plasma methods, exon 19, L858R and exon 20 results, targeted therapy meaning, resistance, and next steps.

EGFR Mutation Test: Lung Cancer, Targeted Therapy, and Results

Learn how EPCAM deletion testing identifies a cause of Lynch syndrome, why deletion analysis matters, what positive and negative results mean, and how findings affect colon cancer surveillance and family testing.

EPCAM Deletion Test: Lynch Syndrome, Colon Cancer Risk, and Results

Learn when ESR1 mutation testing is used in metastatic breast cancer, how plasma and tissue results are interpreted, and how activating variants can guide treatment after hormone therapy resistance.

ESR1 Mutation Test: Breast Cancer, Hormone Therapy Resistance, and Results

1...505152...93 Page 51 of 93